Purdue Pharmaceuticals, L.P.
|Purdue Pharmaceuticals, L.P. Patent applications|
|Patent application number||Title||Published|
|20150238481||Pharmaceutical Formulation Containing Gelling Agent - Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.||08-27-2015|
Patent applications by Purdue Pharmaceuticals, L.P.